Epigral consolidated net profit rises 172.52% in the June 2024 quarter
Sales rise 43.16% to Rs 651.20 crore
Net profit of Epigral rose 172.52% to Rs 85.87 crore in the quarter ended June 2024 as against Rs 31.51 crore during the previous quarter ended June 2023. Sales rose 43.16% to Rs 651.20 crore in the quarter ended June 2024 as against Rs 454.89 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales651.20454.89 43 OPM %27.0720.89 -PBDT164.4178.21 110 PBT130.9647.41 176 NP85.8731.51 173Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jul 24 2024 | 2:12 PM IST